Swapnil R. Patil*, Sandeep C. Atram, Sayali V. Kathale, Neha A. Khadse


Ebola virus, formerly designated Zaire Ebola virus, is one of the five known viruses within the genus Ebola virus which cause disease in humans. Ebola Virus Disease (EVD) has become a public health emergency of international concern. The World Health Organization and Centers for Disease Control and Prevention have developed guidance to educate and inform healthcare workers and travelers worldwide. The natural reservoir of Ebola virus is believed to be bats, particularly fruit bats, and it is primarily transmitted between humans and from animals to humans through body fluids. Ebola is RNA virus that belongs to the family filoviridae, genus Ebola virus. The viruses (EBOV) are enveloped, non-segmented, negative-sense, single-stranded RNA viruses. Ebola virus disease (EVD) was first described in the Democratic Republic of Congo (DRC) in 1976. The exact origin, locations and natural reservoir of Ebola virus remain unclear. People can be exposed to Ebola virus from direct contact with the blood and/or secretions of an infected person. Hunting and butchering of wildlife (great apes and fruit bats) has been identified in previous outbreaks as a potential source of infection. The onset of Ebola virus disease is sudden and early symptoms includes; fever and headache, followed by vomiting and diarrhea. Patients in the final stage of disease die in the clinical picture of massive bleeding, severe dehydration, hypovolemic shock and multi-organ failure. Ebola virus infections can be diagnosed by detecting antigens with an antigen capture ELISA and by detecting viral RNA with Reverse Transcriptase Polymerase Chain Reaction (RT-PCR). No specific treatment has been demonstrated yet to be safe and effective for Ebola virus. Standard treatment currently consists of supportive therapy, including maintenance of blood volume and electrolyte balance, as well as standard nursing care. Prevention and control is mainly based on appropriate precautions to break ways of transmission.

Keywords: Ebola virus disease; viral disease pathogenesis; Ebola viral hemorrhagic fever; Prevention; Zoonotic.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation


    JULY 2021 Issue has been successfully launched on 1 July 2021

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction